{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:41:33Z","timestamp":1774352493022,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nonfunctioning adrenal incidentalomas (NFAIs) are typically considered benign and hormonally inactive, yet emerging evidence suggests a potential association with increased cardiovascular risk. This study aimed to evaluate whether NFAIs are independently associated with vascular damage, assessed through arterial stiffness and carotid Doppler ultrasound. In this observational study, we prospectively enrolled outpatients undergoing evaluation for suspected secondary hypertension at the Arterial Hypertension and Cardiovascular Endocrinology Laboratory of the University of Turin. Patients with NFAI were compared to individuals with essential hypertension and normal adrenal imaging. Cardiometabolic and hemodynamic parameters, including augmentation index (AIx), pulse wave velocity, carotid intima-media thickness, and plaque presence, were assessed. A total of 25 patients with NFAI and 165 controls were included. Univariate analysis revealed a worse cardiometabolic profile in NFAI patients. In multivariable models, NFAI was independently associated with increased arterial stiffness: AIx P2\/P1 (EC 1.097, 95% CI 1.016\u20131.185; p\u2009=\u20090.019), AIx AP\/PP (EC 1.133, 95% CI 1.043\u20131.232; p\u2009=\u20090.004), and AIx@HR75 (EC 1.073, 95% CI 1.004\u20131.147; p\u2009=\u20090.039). Pulse wave velocity was also significantly higher in the NFAI group (EC 2.144, 95% CI 1.021\u20134.502; p\u2009=\u20090.044). Furthermore, NFAI was associated with increased odds of having carotid intima-media thickness \u22650.9\u2009mm (OR 3.312, 95% CI 1.011\u201310.855; p\u2009=\u20090.048), independent of other confounders. This is the first study to demonstrate that NFAI is independently associated with increased arterial stiffness and early vascular remodeling. These findings support the need for systematic cardiovascular risk assessment in patients with NFAI, even in the absence of overt hormonal activity.<\/jats:p>","DOI":"10.1038\/s41440-025-02398-3","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T08:19:27Z","timestamp":1759738767000},"page":"3221-3233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Increased arterial stiffness and atherosclerosis in patients with nonfunctioning adrenal incidentaloma"],"prefix":"10.1038","volume":"48","author":[{"given":"Mirko","family":"Parasiliti-Caprino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Febbraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartolomeo","family":"Sangermano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele Giuseppe","family":"Candela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Arata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Bollati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezio","family":"Ghigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Maccario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"2398_CR1","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J, et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023;189:G1\u2013G42. https:\/\/doi.org\/10.1093\/ejendo\/lvad066.","journal-title":"Eur J Endocrinol"},{"key":"2398_CR2","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1210\/clinem\/dgad044","volume":"108","author":"E Sconfienza","year":"2023","unstructured":"Sconfienza E, Tetti M, Forestiero V, Veglio F, Mulatero P, Monticone S. Prevalence of Functioning Adrenal Incidentalomas: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2023;108:1813\u20131823. https:\/\/doi.org\/10.1210\/clinem\/dgad044.","journal-title":"J Clin Endocrinol Metab"},{"key":"2398_CR3","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1038\/S41440-024-01807-3","volume":"47","author":"M Parasiliti-Caprino","year":"2024","unstructured":"Parasiliti-Caprino M, Roux A, Campioni L, Procopio M, Arata S, Giannelli J, et al. Increased cardiometabolic risk and prevalence of ascending aorta dilation in patients with nonfunctioning adrenal incidentaloma: a retrospective propensity score-matched study. Hypertens Res. 2024;47:2874\u20132883. https:\/\/doi.org\/10.1038\/S41440-024-01807-3.","journal-title":"Hypertens Res"},{"key":"2398_CR4","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/S00268-009-0178-0","volume":"33","author":"Y Erbil","year":"2009","unstructured":"Erbil Y, Ozbey N, Barbaros U, Unalp HR, SalmaslIoglu A, \u00d6zarmagan S. Cardiovascular risk in patients with nonfunctional adrenal incidentaloma: myth or reality?. World J Surg. 2009;33:2099\u20132105. https:\/\/doi.org\/10.1007\/S00268-009-0178-0.","journal-title":"World J Surg"},{"key":"2398_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/S41371-017-0011-4","volume":"32","author":"M Arruda","year":"2017","unstructured":"Arruda M, Mello Ribeiro Cavalari E, Pessoa De Paula M, Fernandes Cordeiro de Morais F, Furtado Bilro G, Alves Coelho MC, et al. The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test. J Hum Hypertens. 2017;32:3\u201311. https:\/\/doi.org\/10.1038\/S41371-017-0011-4.","journal-title":"J Hum Hypertens"},{"key":"2398_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/cen.14745","volume":"97","author":"M Araujo-Castro","year":"2022","unstructured":"Araujo-Castro M. Cardiometabolic profile and urinary metabolomic alterations in non-functioning adrenal incidentalomas: a review. Clin Endocrinol (Oxf). 2022;97:693\u2013701. https:\/\/doi.org\/10.1111\/cen.14745.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2398_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/M16-0547","volume":"165","author":"D Lopez","year":"2016","unstructured":"Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A. \u201cNonfunctional\u201d adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: a cohort study. Ann Intern Med. 2016;165:533\u2013542. https:\/\/doi.org\/10.7326\/M16-0547.","journal-title":"Ann Intern Med"},{"key":"2398_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s40618-014-0106-5","volume":"37","author":"MM Tuna","year":"2014","unstructured":"Tuna MM, Imga NN, Do\u011fan BA, Y\u0131lmaz FM, Top\u00e7uo\u011flu C, Akbaba G, et al. Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis. J Endocrinol Invest. 2014;37:765\u2013768. https:\/\/doi.org\/10.1007\/s40618-014-0106-5.","journal-title":"J Endocrinol Invest"},{"key":"2398_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/J.ENDINU.2019.01.007","volume":"66","author":"R Emral","year":"2019","unstructured":"Emral R, Aydo\u011fan B\u0130, K\u00f6se AD, Demir \u00d6, \u00c7orap\u00e7\u0131o\u011flu D. Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and metabolic syndrome. Endocrinol Diab Nutr. 2019;66:402\u2013409. https:\/\/doi.org\/10.1016\/J.ENDINU.2019.01.007.","journal-title":"Endocrinol Diab Nutr"},{"key":"2398_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1590\/2359-3997000000053","volume":"59","author":"T Delibasi","year":"2015","unstructured":"Delibasi T, Karbek B, Bozkurt NC, Cakir E, Gungunes A, \u00dcnsal \u00d6\u00d6, et al. Circulating E-selectin levels and insulin resistance are associated with early stages of atherosclerosis in nonfunctional adrenal incidentaloma. Arch Endocrinol Metab. 2015;59:310\u2013317. https:\/\/doi.org\/10.1590\/2359-3997000000053.","journal-title":"Arch Endocrinol Metab"},{"key":"2398_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2174\/1871530318666181009112042","volume":"19","author":"G Akkus","year":"2019","unstructured":"Akkus G, Evran M, Sert M, Tetiker T. Adipocytokines in non-functional adrenal incidentalomas and relation with insulin resistance parameters. Endocr Metab Immune Disord Drug Targets. 2019;19:326\u2013332. https:\/\/doi.org\/10.2174\/1871530318666181009112042.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"2398_CR12","doi-asserted-by":"publisher","first-page":"e37635.","DOI":"10.5812\/ijem.37635","volume":"14","author":"NN Imga","year":"2016","unstructured":"Imga NN, Ucar Elalmis O, Muslum Tuna M, Ayc\u0131cek Dogan B, Sahin D, Berker D, et al. The relationship between increased epicardial fat thickness and left ventricular hypertrophy and carotid intima-media thickness in patients with nonfunctional adrenal incidentaloma. Int J Endocrinol Metab. 2016;14:e37635. https:\/\/doi.org\/10.5812\/ijem.37635.","journal-title":"Int J Endocrinol Metab"},{"key":"2398_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/BF03346410","volume":"31","author":"F Ermetici","year":"2008","unstructured":"Ermetici F, Dall'asta C, Malavazos AE, Coman C, Morricone L, Montericcio V, et al. Echocardiographic alterations in patients with non-functioning adrenal incidentaloma. J Endocrinol Invest. 2008;31:573\u2013577. https:\/\/doi.org\/10.1007\/BF03346410.","journal-title":"J Endocrinol Invest"},{"key":"2398_CR14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/J.METABOL.2010.01.007","volume":"59","author":"M Peppa","year":"2010","unstructured":"Peppa M, Boutati E, Koliaki C, Papaefstathiou N, Garoflos E, Economopoulos T, et al. Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?. Metabolism. 2010;59:1435\u20131441. https:\/\/doi.org\/10.1016\/J.METABOL.2010.01.007.","journal-title":"Metabolism"},{"key":"2398_CR15","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/CIRCRESAHA.121.318061","volume":"128","author":"P Boutouyrie","year":"2021","unstructured":"Boutouyrie P, Chowienczyk P, Humphrey JD, Mitchell GF. Arterial stiffness and cardiovascular risk in hypertension. Circ Res. 2021;128:864\u2013886. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318061.","journal-title":"Circ Res"},{"key":"2398_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","volume":"115","author":"MW Lorenz","year":"2007","unstructured":"Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation. 2007;115:459\u2013467. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.628875.","journal-title":"Circulation"},{"key":"2398_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7326\/0003-4819-128-4-199802150-00002","volume":"128","author":"HN Hodis","year":"1998","unstructured":"Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, et al. The role of carotid arterial intima - Media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128:262\u2013269. https:\/\/doi.org\/10.7326\/0003-4819-128-4-199802150-00002.","journal-title":"Ann Intern Med"},{"key":"2398_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1055\/s-0042-109866","volume":"125","author":"GB Cansu","year":"2017","unstructured":"Cansu GB, Sari R, Yilmaz N, \u00d6zdem S, \u00c7ubuk M. Markers of subclinical cardiovascular disease in nonfunctional adrenal incidentaloma patients without traditional cardiovascular risk factors. Exp Clin Endocrinol Diab. 2017;125:57\u201363. https:\/\/doi.org\/10.1055\/s-0042-109866.","journal-title":"Exp Clin Endocrinol Diab"},{"key":"2398_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12020-017-1439-6","volume":"58","author":"T Akkan","year":"2017","unstructured":"Akkan T, Altay M, \u00dcnsal Y, Da\u011fdeviren M, Beyan E. Nonfunctioning adrenal incidentaloma affecting central blood pressure and arterial stiffness parameters. Endocrine. 2017;58:513\u2013520. https:\/\/doi.org\/10.1007\/s12020-017-1439-6.","journal-title":"Endocrine"},{"key":"2398_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"key":"2398_CR21","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1097\/00019048-200106000-00021","volume":"285","author":"JI Cleeman","year":"2001","unstructured":"Cleeman JI. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treat panel III). J Am Med Assoc. 2001;285:2486\u20132497. https:\/\/doi.org\/10.1097\/00019048-200106000-00021.","journal-title":"J Am Med Assoc"},{"key":"2398_CR22","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874\u20132071. https:\/\/doi.org\/10.1097\/HJH.0000000000003480.","journal-title":"J Hypertens"},{"key":"2398_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1161\/01.HYP.0000200695.34024.4c","volume":"47","author":"Y Li","year":"2006","unstructured":"Li Y, Wang JG, Dolan E, Gao PJ, Guo HF, Nawrot T, et al. Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension. 2006;47:359\u2013364. https:\/\/doi.org\/10.1161\/01.HYP.0000200695.34024.4c.","journal-title":"Hypertension"},{"key":"2398_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000452448","volume":"4","author":"M Butlin","year":"2017","unstructured":"Butlin M, Qasem A. Large Artery Stiffness Assessment Using SphygmoCor Technology. Pulse (Basel). 2017;4:180\u2013192. https:\/\/doi.org\/10.1159\/000452448.","journal-title":"Pulse (Basel)"},{"key":"2398_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/HJH.0000000000003935","volume":"43","author":"A Giudici","year":"2025","unstructured":"Giudici A, Grillo A, Scalise F, Reesink KD, Delhaas T, Salvi P, et al. Beat-to-beat variability of aortic pulse wave velocity: implications for aortic stiffness measurements. J Hypertens. 2025;43:589\u2013597. https:\/\/doi.org\/10.1097\/HJH.0000000000003935.","journal-title":"J Hypertens"},{"key":"2398_CR26","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/S003300100963","volume":"11","author":"P Landwehr","year":"2001","unstructured":"Landwehr P, Schulte O, Voshage G. Ultrasound examination of carotid and vertebral arteries. Eur Radio. 2001;11:1521\u20131534. https:\/\/doi.org\/10.1007\/S003300100963.","journal-title":"Eur Radio"},{"key":"2398_CR27","doi-asserted-by":"publisher","first-page":"E973","DOI":"10.1210\/CLINEM\/DGZ284","volume":"105","author":"G Reimondo","year":"2020","unstructured":"Reimondo G, Castellano E, Grosso M, Priotto R, Puglisi S, Pia A, et al. Adrenal incidentalomas are tied to increased risk of diabetes: Findings from a prospective study. J Clin Endocrinol Metab. 2020;105:E973\u2013E981. https:\/\/doi.org\/10.1210\/CLINEM\/DGZ284.","journal-title":"J Clin Endocrinol Metab"},{"key":"2398_CR28","doi-asserted-by":"publisher","unstructured":"Y\u0131lmaz F, S\u00f6zel H, Kele\u015f M, Y\u0131lmaz \u00dc Frequency of masked hypertension in patients with nonfunctioning adrenal incidentalomas with normal and high normal blood pressure. Ir J Med Sci. Published online 2021. https:\/\/doi.org\/10.1007\/s11845-021-02734-9.","DOI":"10.1007\/s11845-021-02734-9"},{"key":"2398_CR29","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1507\/endocrj.EJ18-0066","volume":"65","author":"A Babinska","year":"2018","unstructured":"Babinska A, Kaszubowski M, Sworczak K. Adipokine and cytokine levels in non-functioning adrenal incidentalomas (NFAI). Endocr J. 2018;65:849\u2013858. https:\/\/doi.org\/10.1507\/endocrj.EJ18-0066.","journal-title":"Endocr J"},{"key":"2398_CR30","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/J.METABOL.2006.12.018","volume":"56","author":"F Ermetici","year":"2007","unstructured":"Ermetici F, Malavazos AE, Corbetta S, Morricone L, Dall'Asta C, Corsi MM, et al. Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma. Metabolism. 2007;56:686\u2013692. https:\/\/doi.org\/10.1016\/J.METABOL.2006.12.018.","journal-title":"Metabolism"},{"key":"2398_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s40618-018-0985-y","volume":"42","author":"AB Moraes","year":"2019","unstructured":"Moraes AB, Cavalari EMR, de Paula MP, Arruda M, Curi D, Leit\u00e3o RA, et al. Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome?. J Endocrinol Invest. 2019;42:797\u2013807. https:\/\/doi.org\/10.1007\/s40618-018-0985-y.","journal-title":"J Endocrinol Invest"},{"key":"2398_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.5935\/ABC.20180188","volume":"111","author":"G Sokmen","year":"2018","unstructured":"Sokmen G, Sahin M, Tuzun D, Sokmen A, Bolat H, Oguz A, et al. Assessment of Subclinical Cardiac Alterations and Atrial Electromechanical Delay by Tissue Doppler Echocardiography in Patients with Nonfunctioning Adrenal Incidentaloma. Arq Bras Cardiol. 2018;111:656\u2013663. https:\/\/doi.org\/10.5935\/ABC.20180188.","journal-title":"Arq Bras Cardiol"},{"key":"2398_CR33","doi-asserted-by":"publisher","unstructured":"Bollati M, Lopez C, Bioletto F, Ponzetto F, Ghigo E, Maccario M, et al. Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/IJMS23042111.","DOI":"10.3390\/IJMS23042111"},{"key":"2398_CR34","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1007\/S40618-024-02440-0","volume":"47","author":"V Favero","year":"2024","unstructured":"Favero V, Parazzoli C, Bernasconi DP, Chiodini I. Cardiometabolic comorbidities and cardiovascular events in \u201cnon-functioning\u201d adrenal incidentalomas: a systematic review and meta-analysis. J Endocrinol Invest. 2024;47:2929\u20132942. https:\/\/doi.org\/10.1007\/S40618-024-02440-0.","journal-title":"J Endocrinol Invest"},{"key":"2398_CR35","doi-asserted-by":"publisher","first-page":"e536","DOI":"10.1210\/CLINEM\/DGAD074","volume":"108","author":"A Kjellbom","year":"2023","unstructured":"Kjellbom A, Lindgren O, Danielsson M, Olsen H, L\u00f6ndahl M. Mortality not increased in patients with nonfunctional adrenal adenomas: a matched cohort study. J Clin Endocrinol Metab. 2023;108:e536\u2013e541. https:\/\/doi.org\/10.1210\/CLINEM\/DGAD074.","journal-title":"J Clin Endocrinol Metab"},{"key":"2398_CR36","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1210\/JC.2013-4064","volume":"99","author":"II Androulakis","year":"2014","unstructured":"Androulakis II, Kaltsas GA, Kollias GE, Markou AC, Gouli AK, Thomas DA, et al. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion. J Clin Endocrinol Metab. 2014;99:2754\u20132762. https:\/\/doi.org\/10.1210\/JC.2013-4064.","journal-title":"J Clin Endocrinol Metab"},{"key":"2398_CR37","doi-asserted-by":"publisher","first-page":"674734.","DOI":"10.1155\/2015\/674734","volume":"2015","author":"G Reimondo","year":"2015","unstructured":"Reimondo G, Allasino B, Coletta M, Pia A, Peraga G, Zaggia B, et al. Evaluation of midnight salivary cortisol as a predictor factor for common carotid arteries intima media thickness in patients with clinically inapparent adrenal adenomas. Int J Endocrinol. 2015;2015:674734. https:\/\/doi.org\/10.1155\/2015\/674734.","journal-title":"Int J Endocrinol"},{"key":"2398_CR38","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1210\/JC.2019-00365","volume":"104","author":"G Di Dalmazi","year":"2019","unstructured":"Di Dalmazi G, Fanelli F, Zavatta G, Ricci Bitti S, Mezzullo M, Repaci A, et al. The steroid profile of adrenal incidentalomas: subtyping subjects with high cardiovascular risk. J Clin Endocrinol Metab. 2019;104:5519\u20135528. https:\/\/doi.org\/10.1210\/JC.2019-00365.","journal-title":"J Clin Endocrinol Metab"},{"key":"2398_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19321-2","volume":"12","author":"M Parasiliti-Caprino","year":"2022","unstructured":"Parasiliti-Caprino M, Lopez C, Bollati M, Bioletto F, Sola C, Di Carlo MC, et al. A retrospective study on the association between urine metanephrines and cardiometabolic risk in patients with nonfunctioning adrenal incidentaloma. Sci Rep. 2022;12:14913. https:\/\/doi.org\/10.1038\/s41598-022-19321-2.","journal-title":"Sci Rep"},{"key":"2398_CR40","doi-asserted-by":"publisher","first-page":"1967.","DOI":"10.3390\/jcm10091967","volume":"10","author":"M Parasiliti-Caprino","year":"2021","unstructured":"Parasiliti-Caprino M, Obert C, Lopez C, Bollati M, Bioletto F, Bima C, et al. Association of urine metanephrine levels with cardiometabolic risk: an observational retrospective study. J Clin Med. 2021;10:1967. https:\/\/doi.org\/10.3390\/jcm10091967.","journal-title":"J Clin Med"},{"key":"2398_CR41","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/07435809609043773","volume":"22","author":"M Reincke","year":"1996","unstructured":"Reincke M, Fa\u00dfnacht M, V\u00e4th S, Mora P, Allolio B. Adrenal incidentalomas: a manifestation of the metabolic syndrome?. Endocr Res. 1996;22:757\u2013761. https:\/\/doi.org\/10.1080\/07435809609043773.","journal-title":"Endocr Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02398-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02398-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02398-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T02:57:48Z","timestamp":1768359468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02398-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2398"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02398-3","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}